Cph have imo postioned themselves firmly into cannabis market great for investors http://www.nextbiotech.com.au/cph-a...UA7&utm_source=facebook.com&utm_medium=social
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling